Antennova, a clinical-stage biotech company focused on oncology today announced the presentation of latest data from its Phase I/II CLINCH study ongoing in China and Australia evaluating ATN-022 ...
The Safer Drugs Consumption Facility in Glasgow opened on 13 January, letting people take substances under supervision. The proposed value of its new contract is £4.8m - about £300,000 lower ...
The world's leading insulin manufacturer faces critical decisions as weight-loss drug demand strains production capacity. Market forces threaten the company's ability to serve all patients effectively ...
Scientists develop DNA nanorobots capable of modifying artificial cells. Scientists at the University of Stuttgart have successfully used "DNA origami" to control the structure and function of ...